Cvs Pharmacy # 02309 | |
3020 Windward Plz, Alpharetta, Georgia 30005 | |
(770) 475-3638 |
Name | Cvs Pharmacy # 02309 |
---|---|
Organization Name | Georgia Cvs Pharmacy, L.l.c. |
Location | 3020 Windward Plz, Alpharetta, Georgia 30005 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (770) 475-3638 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Refractory cardiac arrest patients brought to hospital with ongoing cardiopulmonary resuscitation (CPR) can survive with good brain function, according to research in nearly 4 000 patients presented at ESC Congress today by Dr Helle Søholm, a cardiologist at Copenhagen University Hospital Righospitalet in Denmark.
Cardiome Pharma Corp. today announced that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada, other than Québec, and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
AbbVie today announced its investigational medicine venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, has been granted Breakthrough Therapy Designation by the FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
Women in western countries are more likely to die from heart disease than from cancer.
› Verified 8 days ago
NPI Number | 1356445282 |
Organization Name | GEORGIA CVS PHARMACY, L.L.C. |
Doing Business As | CVS PHARMACY #02309 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 3020 Windward Plz, Alpharetta, GA 30005 |
Phone Number | 770-475-3638 |
News Archive
Refractory cardiac arrest patients brought to hospital with ongoing cardiopulmonary resuscitation (CPR) can survive with good brain function, according to research in nearly 4 000 patients presented at ESC Congress today by Dr Helle Søholm, a cardiologist at Copenhagen University Hospital Righospitalet in Denmark.
Cardiome Pharma Corp. today announced that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada, other than Québec, and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
AbbVie today announced its investigational medicine venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, has been granted Breakthrough Therapy Designation by the FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
Women in western countries are more likely to die from heart disease than from cancer.
› Verified 8 days ago
News Archive
Refractory cardiac arrest patients brought to hospital with ongoing cardiopulmonary resuscitation (CPR) can survive with good brain function, according to research in nearly 4 000 patients presented at ESC Congress today by Dr Helle Søholm, a cardiologist at Copenhagen University Hospital Righospitalet in Denmark.
Cardiome Pharma Corp. today announced that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada, other than Québec, and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
AbbVie today announced its investigational medicine venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, has been granted Breakthrough Therapy Designation by the FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
Women in western countries are more likely to die from heart disease than from cancer.
› Verified 8 days ago
Bio-tech Orthotic & Prothetic Servi Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4895 Windward Pkwy, Alpharetta, Georgia 30004 Phone: (404) 600-2072 | |
Cornerstone Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2660 Holcomb Bridge Rd, Alpharetta, Georgia 30022 Phone: (770) 399-7337 | |
Cvs Pharmacy # 02185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 184 N Main St, Alpharetta, Georgia 30009 Phone: (678) 297-1089 | |
Cvs Pharmacy # 02309 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3020 Windward Plz, Alpharetta, Georgia 30005 Phone: (770) 475-3638 | |
Cvs Pharmacy # 02539 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5740 Atlanta Hwy, Alpharetta, Georgia 30004 Phone: (678) 366-7954 |